HEIGHTS CAPITAL MANAGEMENT, INC
Position in PMN — ProMIS Neurosciences Inc.
CIK 1081698
SAN FRANCISCO, CA
Position in PMN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$643,382
+$630,596 QoQ
Shares Held
50,660
+6830.2% QoQ
Ownership
0.565%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PMN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026HEIGHTS CAPITAL MANAGEMENT, INC holds $34,693,958 across 12 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MGTX |
MeiraGTx Holdings plc
|
850,000 | $11,483,500 | |
| 2 | TSHA |
Taysha Gene Therapies, Inc.
|
1,500,000 | $10,215,000 | |
| 3 | PRQR |
ProQR Therapeutics N.V.
|
2,762,430 | $5,138,119 | |
| 4 | CABA |
Cabaletta Bio, Inc.
|
755,626 | $2,349,996 | |
| 5 | MLTX |
MoonLake Immunotherapeutics
|
100,000 | $1,947,000 | |
| 6 | CALC |
CalciMedica, Inc.
|
311,216 | $1,602,763 | |
| 7 | QURE |
uniQure N.V.
|
25,000 | $1,151,500 | |
| 8 | RANI |
Rani Therapeutics Holdings, Inc.
|
934,580 | $710,280 |
All Filings in PMN
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $643,382 | 50,660 | Shares | Other | 2026-05-15 | |
| 2025-03-31 | $12,786 | 18,267 | Shares | Other | 2025-05-14 | |
| 2024-12-31 | $152,196 | 160,207 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $483,617 | 386,894 | Shares | Defined | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||